There is also evidence supporting the effectiveness of SGLT‐2 inhibitors, thiazolidinediones, and glucagon‐like peptide‐1 (GLP‐1) analogs in controlling alpelisib‐associated hyperglycemia. The gene discussed is SLC5A2; the disease is Hyperglycemia.